4//SEC Filing
HALKUFF DAWN 4
Accession 0001867096-23-000151
CIK 0001867096other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:20 PM ET
Size
5.5 KB
Accession
0001867096-23-000151
Insider Transaction Report
Form 4
HALKUFF DAWN
Director
Transactions
- Purchase
Common Stock
2023-11-20$1.84/sh+5,410$9,954→ 5,410 total(indirect: By Trust)
Holdings
- 57,500
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001743658
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 4:20 PM ET
- Size
- 5.5 KB